INVITROGEN has announced the launch of its GIBCO OpTmizer T-cell Expansion SFM which has been created as a solution for culturing and expanding human T-cells which do not require the addition of serum.
OpTmizer SFM has been developed to allow scientists to advance research on the central role T-cells play in the human immune response.
Invitrogen says the OpTmizer SFM has been designed to enable superior cell growth and viability with consistent results while eliminating the need for the addition of human serum, which saves money and contamination risk.
The OpTmzer SFM is xeno-free and is available in Research Use Only grade, manufactured under cGMP regulations and is equipped with FDA Drug Master File to support regulatory filings.